Study Suggests Early Statin Use May Reduce Dementia Risk in Type 2 Diabetes Patients

An observational study presented at ESC Congress 2026 and published in The Lancet Regional Health – Europe suggests that early statin initiation after a type 2 diabetes diagnosis is associated with a 15% lower relative risk of dementia over 10 years. While not proving causation, these findings are significant due to statins' widespread availability and low cost, potentially offering a strategy to mitigate dementia risk in a vulnerable population.